2[2]Matthew WD, Sandrok AW. Cyclophophamide treatment used to manipulate the immune response for the production of monoclonal antibodoes. J Immunol Methods, 1987, 100:73.
3[3]Salata RA, Maihotra IJ, Hampson RK, et al. Application of an immune tolarization procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone. Anal Biochemistry, 1992, 207: 142.
4[5]Brooks PC, Lin JM, French DL, et al. Substractive immunization yields monoclonal antibodies that specifically inhibit metastasis. J Cell Biol, 1993,122(6): 1351.
5Gavilondo-cowley JV, Coloma M J, Vazuez J, et al. Specific amplification of rearranged immunoglobulin variable region genes from mouse Hybridoma cells [ J ]. Hybridoma, 1990; 9 ( 5 ) :407 - 416.
6Warrens AN, Jones MD, Lechler RI. Splicing by overlap extension by PCR using asymmetric amplification: An improved technique for the generation of hybrid proteins of immunological interest [ J ].Gene, 1997;186(1) :29 -35.
7Chio CL, Huff, Rita M. Binding assay employing a synthetic gene for D4 dopamine receptors [ J]. Biotechnol Advances, 1997; 15 ( 1 ):72 -73.
8Varela M, Sala M, Llovet JM, et al. Treatment of hepatocellular carcinoma: Is there an optimal strategy? [J]. Cancer Treat Rev,2003 ;29(2) :99 - 104.
9Zhang J, Liu YF, Yang SJ, et al. Primary targeting of recombinant Fv-immunotoxin hscFv25-mTNF against hepatocellular carcinoma[J]. World J Gastroenterol, 2004;10(13) :1872 - 1875.
